Oxford University

Category

“Operation Warp Speed” Moves to Warp 2: AstraZeneca Begins Phase 3, Experts Skeptical as Trump Administration Prepares for November 1 Vaccine Delivery, and Speed-Up May Involve an EUA

Monday, AstraZeneca said it has begun Phase 3 trials of AZD1222, its COVID-19 vaccine candidate. This makes them the third firm to be in Phase 3 for the virus. As chronicled by CNN August 31 and updated September 1, the vaccine is developed with Oxford University and...

The AstraZeneca Phase 3 COVID-19 Vaccine Study: Unprecedented Compression of Timeline of Est. Start Date to Est. Primary Completion Date

Is President Trump preparing to fast track the AstraZeneca COVID-19 vaccine known as AZD1222? According to a report in the Financial Times, this is exactly what is being contemplated as the administration would “bypass normal regulatory standards to fast-track”...

MedPharmics Selected by AstraZeneca for Phase 3 COVID-19 Vaccine Trial: First Site in New Mexico to Enroll Soon

MedPharmics LLC, based in Louisiana, has mobilized its Albuquerque, New Mexico trial site location to support a COVID-19 vaccine clinical trial sponsored by AstraZeneca and Oxford University. In fact, this will be the first such site in all of New Mexico to enroll...

Orlando Immunology Center the Only Site in Florida Selected for the AstraZeneca/Oxford Phase 3 COVID-19 Vaccine (AZD1222) Trial

The Orlando Immunology Center, a prominent central Florida HIV, hepatitis and infectious disease practice, claims it’s the only such health provider in the state of Florida selected by the National Institutes of Health (under a new and consolidated site network called...

Pin It on Pinterest